Page 30 - Linical Evolution News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Patients with early breast cancer (EBC) could benefit from a targeted treatment that can block or interfere with cancer cell growth.

In the second and final part of an interview with Medable’s chief growth officer and women’s health champion, Sanskriti Thakur, discover her views on vital changes that need to be made. She discusses ways to ensure the importance of women’s roles in clinical trials is recognized, how decentralized trials will become the norm and accessible to all - regardless of sex, race, color, or creed.

A powerful tool that could capture abdominal aortic aneurysms (AAA) and refer those at risk is the first to be given clearance by the US Food and Drink Administration (FDA).

The company launches its new ZS300 sensor, ZB200 bridge and Android sensor discovery app, which will be made available for use with the supply chains of the pharma and food industries.

Non-clinical research has been published about roginolisob, iOnctura’s non-ATP competitive alloseteric modulator of PI3Kδ, for the potential treatment of patients with solid and hematological tumors.